Loading...

Background

Why was GAFIO established

The global incidence of cancer continues to rise, both in high-income countries and, especially, in low- and middle-income countries. In 2020, there were approximately 19.3 million newly diagnosed cancer cases, and 10.0 million cancer-related deaths worldwide. By 2050, the number of cancer cases is predicted to increase 77% to 35 million cases. Meanwhile, the economic cost for cancer treatment and care has been escalating 6%-9% annually, standing at around US$550 billion as of 2020. Moreover, geographic and economic barriers result in significant disparities in cancer survival rates between high-, middle- and low-income countries, for instance 67% in the US, 50% in India, and as low as 30% in sub-Saharan Africa. The escalating cost and complexity of cancer treatment necessitate a radical transformation in cancer care.

19.3 M

diagnosed cancer

10.0 M

related deaths

550 B USD

economic cost

9.0 %

escalating annually

GAFIO offers three types

Membership Types

Professional Background: Individuals applying for membership should have a background or interest in oncology, informatics, artificial intelligence, or related fields.
Qualifications: Applicants may be required to hold a bachelor's degree or higher in a relevant field, such as medicine, informatics, engineering, or related disciplines.
Commitment to GAFIO’s Mission: Prospective members should support GAFIO's mission and goals, which often involve advancing oncology, AI, and patient care through education, research, and collaboration.
Relevant Experience: While not always mandatory, having professional experience or involvement in oncology or AI-related activities can strengthen an individual's application for membership.

Relevant Background:  Open to residents, fellows, and students enrolled in relevant undergraduate, graduate, doctoral, post-doctoral, or resident training programs.
Commitment to GAFIO’s Mission: Prospective members should support GAFIO's mission and goals, which often involve advancing oncology, AI, and patient care through education, research, and collaboration.

Organizational Profile: Corporate members are typically entities such as hospitals, medical institutions, research organizations, and companies involved in healthcare, oncology, AI, or related industries.
Commitment to GAFIO's Mission: Similar to individual members, corporate members should align with GAFIO's mission and goals, especially in areas related to oncology, AI, and healthcare innovation.
Legal Entity Status: Corporate members must have legal entity qualifications or represent social groups with an interest in oncology, AI, or related social welfare activities.
Financial Commitment: Corporate members may be required to pay membership dues or fees based on their organizational size or membership tier.

Latest News

10/14/2026
AI Meets Neural Stem Cells: Can Computational Modeling Help Prioritize Brain Tumor Therapy Research?

Neural stem cells are being explored as carriers of anticancer payloads for malignant brain tumors. But a key question remains: which features of these therapeutic cells could help sustain tumor suppression, rather than produce only a temporary response? Computational modeling offers a way to explore this question before moving to experimental testing.

Read More
10/11/2026
AI Meets Medical Imaging: How Do We Unlock the Full Potential of Intelligent Oncology Without Compromising Privacy?

AI is transforming cancer screening, tumor segmentation, and precision treatment planning. But a fundamental tension persists: the more powerful the model, the deeper its reliance on massive, highly sensitive datasets — and medical images are among the most private data imaginable.

Read More
9/22/2026
Top 5 Most-Cited Articles in Intelligent Oncology (2025)!

According to the latest citation data from the Scopus database, we have compiled the top 5 most-cited review articles published in Intelligent Oncology in 2025. These articles focus on the deep intersection and cutting-edge applications of AI in oncology, pathology, and multi-omics, demonstrating exceptional academic impact!

Read More

Becoming a member

If you have a common vision with us, join us

Image

Please fill out the form

Fill in this information to help us understand you and create a private profile for you.

Email available
Email unavailable
Get
Verification code required
Password required
Confirm password required
Please select country or region
Please select member type
First Name required
Last/Family Name required
Please select gender
Please select Academic Degree
Affiliation required
Major Focus required
Cancer Subspecialties required